The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of HSCT vs consolidation therapy for AML patients aged 60-75 in CR1: A randomized phase III, multicentre EBMT study.
 
Dietger Niederwieser
No Relationships to Disclose
 
Bob Lowenberg
Consulting or Advisory Role - Agios; Astex Pharmaceuticals; Celgene; Clear Creek Bio
 
Wolfgang E. Berdel
No Relationships to Disclose
 
Ronald Brand
No Relationships to Disclose
 
Yves Chalandon
No Relationships to Disclose
 
Christian Junghanss
No Relationships to Disclose
 
Dirk Hasenclever
No Relationships to Disclose
 
Mathias Haenel
No Relationships to Disclose
 
Georg Maschmeyer
No Relationships to Disclose
 
Meinhard Mende
No Relationships to Disclose
 
Mohamad Mohty
No Relationships to Disclose
 
Gert Ten Ossenkoppele
Honoraria - Roche
Consulting or Advisory Role - Amgen; Celgene; CTI; Janssen; Novartis; Pfizer; Roche; Sunesis Pharmaceuticals
Research Funding - Amgen (Inst); Celgene (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Roche
 
Jakob Passweg
No Relationships to Disclose
 
Herbert Sayer
No Relationships to Disclose
 
Johannes Schetelig
No Relationships to Disclose
 
Harry C. Schouten
Honoraria - Alexion Pharmaceuticals; Gilead Sciences; Novartis; Sanofi
Travel, Accommodations, Expenses - Alexion Pharmaceuticals
 
Sebastian Schwind
No Relationships to Disclose
 
Matthias Stelljes
No Relationships to Disclose
 
Vladan Vucinic
No Relationships to Disclose
 
Jan Cornelissen
No Relationships to Disclose